Podiatrist · Bayside, NY
NPI
1104095744
Since 2008
Specialty
Podiatrist
Code 213E00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
21909 Northern Blvd
Bayside, NY, 11361
Phone (718) 229-9200
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,042 services
Medicare patients, 2024
219
Average age 77
Drug cost, 2024
$5.4M
19,264 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kwangsu Kim was code 99213 (office e&m - established), 371 times for 185 patients. In total Kwangsu Kim billed 1,042 services in 20 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 371 | 185 | $80.15 | $30K |
| 73630 X-ray - Lower Extremity | Office | 213 | 99 | $32.86 | $7,000 |
| 11730 Nail Procedure | Office | 105 | 78 | $107.78 | $11K |
| 17110 Destruction Skin Lesion | Office | 104 | 76 | $106.27 | $11K |
| 73610 X-ray - Lower Extremity | Office | 81 | 42 | $35.47 | $2,873 |
| 99214 Office E&M - Established | Office | 50 | 49 | $112.78 | $5,639 |
| 11732 Nail Procedure | Office | 31 | 31 | $31.18 | $967 |
| 99203 Office E&M - New | Office | 25 | 25 | $87.18 | $2,180 |
| 76882 Ultrasound - Nonspecific | Office | 22 | 21 | $58.86 | $1,295 |
| 20606 Joint Injection | Office | 19 | 18 | $76.99 | $1,463 |
By year: 2022 $134K for 1,816 services; 2023 $80K for 1,107 services; 2024 $76K for 1,042 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kwangsu Kim prescribed most often to Medicare patients was Diclofenac Epolamine, with 5,425 prescriptions and refills. In total Kwangsu Kim wrote 19,264 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Epolamine Generic | 5,425 | 5,574 | 850 | $3.1M |
| Ammonium Lactate Generic | 2,473 | 3,383 | 707 | $52K |
| Jublia Efinaconazole | 1,482 | 1,899 | 320 | $1.8M |
| Mupirocin Generic | 1,452 | 1,479 | 548 | $10K |
| Mometasone Furoate Generic | 1,399 | 1,503 | 418 | $17K |
| Diclofenac Sodium Generic | 1,367 | 1,927 | 439 | $61K |
| Clotrimazole Generic | 1,303 | 1,478 | 401 | $34K |
| Ciclopirox Ciclopirox Olamine | 603 | 622 | 144 | $16K |
| Meloxicam Generic | 527 | 531 | 248 | $1,115 |
| Halobetasol Propionate Generic | 524 | 553 | 108 | $29K |
| Fluconazole Generic | 404 | 764 | 125 | $8,863 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 387 | 424 | 135 | $6,035 |
| Cilostazol Generic | 367 | 381 | 80 | $1,698 |
| Clobetasol Propionate Generic | 285 | 285 | 74 | $13K |
| Ketoconazole Generic | 253 | 258 | 59 | $5,155 |
Brand drugs: - claims; generic drugs: 12,210 claims; opioid claims: 12.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kwangsu Kim were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.